Completed study

Official Study Title
A randomized clinical trial for enhanced trained immune responses through Bacillus Calmette-Guérin vaccination to prevent infections by COVID-19

Brief Description
ACTIVATE-II is a randomized clinical trial aiming to investigate if the developing concept of trained immunity i.e. the memory of the innate immune system coming after vaccination exists in humans and may lead to protection from COVID-19.

Details
Status: Completed
Study Type: Interventional (Clinical Trial)
Study phase: II
Study sites: 11 sites in Greece
Enrolled: 301 participants

ClinicalTrials.gov Identifier: NCT04414267
EudraCT number: 2020-002448-21

Start of trial: May 26th, 2020
End of trial: May 7th, 2021

Condition/Disease studied: COVID-19; Virus Diseases; Corona Virus Infection; Coronary Heart Disease; Chronic Obstructive Pulmonary Disease
Keywords: COVID-19; SARS-CoV-2; Vaccination; Bacillus Calmette-Guérin vaccination

Related publications